Table 4.

Effect of HBAO on plasma insulin level in normal control and STZ-induced diabetic treated rats.

Groups	Plasma insulin (μIU/ml) level at different periods of time in normal control and STZ-induced diabetic treated rats
	At start of therapy	At 22 days of therapy	At the end of therapy (on 45th day)
Group 1	14.42±0.20	15.37±0.18	16.19±0.13
Group 2	14.71±0.15	14.67±0.33	16.90±0.34
Group 3	4.18±0.004a	4.81±0.04a	10.38±6.65a
Group 4	4.29±0.01	4.86±0.18	8.5±0.16*
Group 5	4.34±0.02	6.79±0.06*	10.5±0.14**
Group 6	4.49±0.02	9.67±0.17**	13.66±0.17***
Group 7	4.82±0.07	11.42±0.19**	14.84±0.27***

The data are expressed as mean ± SEM. The comparisons were made by one way ANOVA followed by Dunnett’s test.

^*p<0.05 is considered significant when compared to the control group (0 h)

^**p<0.001 is considered very significant when compared to the control group (0 h)

^***p<0.001 is considered extremely significant when compared to the control group (0 h).

^a – compared to normal; * – compared to diabetic control